| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 157 | 2021 | 13485 | 7.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 76 | 2021 | 5387 | 5.470 |
Why?
|
| Adenocarcinoma | 69 | 2018 | 6359 | 4.200 |
Why?
|
| Quinazolines | 26 | 2016 | 1367 | 3.610 |
Why?
|
| Taiwan | 45 | 2020 | 521 | 2.340 |
Why?
|
| Mutation | 50 | 2021 | 30213 | 1.710 |
Why?
|
| Small Cell Lung Carcinoma | 6 | 2018 | 454 | 1.390 |
Why?
|
| Genes, erbB-1 | 5 | 2014 | 161 | 1.390 |
Why?
|
| Severe Acute Respiratory Syndrome | 6 | 2006 | 136 | 1.340 |
Why?
|
| Antineoplastic Agents | 31 | 2021 | 13643 | 1.230 |
Why?
|
| Protein Kinase Inhibitors | 18 | 2021 | 5690 | 1.180 |
Why?
|
| Neoplasm Invasiveness | 23 | 2016 | 3609 | 1.040 |
Why?
|
| Antitubercular Agents | 7 | 2015 | 1380 | 1.000 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 3 | 2014 | 83 | 1.000 |
Why?
|
| Gene Expression Regulation, Neoplastic | 28 | 2020 | 8621 | 0.960 |
Why?
|
| Aged | 148 | 2020 | 171343 | 0.950 |
Why?
|
| Aged, 80 and over | 80 | 2018 | 59550 | 0.930 |
Why?
|
| Prognosis | 47 | 2017 | 29948 | 0.910 |
Why?
|
| Ventilator Weaning | 4 | 2008 | 170 | 0.900 |
Why?
|
| Middle Aged | 154 | 2020 | 223257 | 0.880 |
Why?
|
| Cell Movement | 14 | 2021 | 5199 | 0.880 |
Why?
|
| Carcinoma, Squamous Cell | 14 | 2021 | 4049 | 0.850 |
Why?
|
| Neoplasm Staging | 30 | 2017 | 11218 | 0.840 |
Why?
|
| Osteogenesis | 4 | 2021 | 1282 | 0.800 |
Why?
|
| Male | 177 | 2021 | 364142 | 0.800 |
Why?
|
| Biomarkers, Pharmacological | 2 | 2015 | 161 | 0.790 |
Why?
|
| Lung Diseases | 7 | 2009 | 1941 | 0.790 |
Why?
|
| Tuberculosis, Pulmonary | 7 | 2019 | 836 | 0.760 |
Why?
|
| Pleurodesis | 2 | 2014 | 49 | 0.750 |
Why?
|
| Female | 178 | 2020 | 396520 | 0.740 |
Why?
|
| Pneumothorax | 4 | 2014 | 393 | 0.740 |
Why?
|
| Tuberculosis | 8 | 2015 | 2011 | 0.730 |
Why?
|
| Pseudopodia | 2 | 2012 | 168 | 0.730 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 2 | 2012 | 117 | 0.720 |
Why?
|
| Periodontal Ligament | 1 | 2021 | 117 | 0.720 |
Why?
|
| Survival Analysis | 27 | 2019 | 10100 | 0.720 |
Why?
|
| Neoplasm Metastasis | 22 | 2020 | 4891 | 0.710 |
Why?
|
| Community-Acquired Infections | 5 | 2009 | 470 | 0.710 |
Why?
|
| Humans | 238 | 2021 | 766766 | 0.670 |
Why?
|
| Guanine | 2 | 2011 | 280 | 0.660 |
Why?
|
| Genes, p53 | 3 | 2016 | 711 | 0.660 |
Why?
|
| Neoplastic Stem Cells | 6 | 2021 | 1351 | 0.660 |
Why?
|
| Glutamates | 2 | 2011 | 384 | 0.660 |
Why?
|
| Nerve Tissue Proteins | 6 | 2017 | 4400 | 0.650 |
Why?
|
| Antigens, Neoplasm | 5 | 2016 | 1998 | 0.640 |
Why?
|
| Cell Line, Tumor | 35 | 2021 | 17088 | 0.620 |
Why?
|
| Adult | 105 | 2019 | 223307 | 0.610 |
Why?
|
| Lipopolysaccharides | 4 | 2021 | 2214 | 0.590 |
Why?
|
| Lung | 10 | 2017 | 10067 | 0.590 |
Why?
|
| DNA, Neoplasm | 7 | 2014 | 1741 | 0.570 |
Why?
|
| Mice, SCID | 16 | 2018 | 2628 | 0.570 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2016 | 4522 | 0.560 |
Why?
|
| Respiration, Artificial | 7 | 2008 | 2727 | 0.550 |
Why?
|
| Neoplasm Proteins | 7 | 2016 | 3601 | 0.540 |
Why?
|
| STAT1 Transcription Factor | 2 | 2016 | 340 | 0.530 |
Why?
|
| Oncogene Proteins, Fusion | 5 | 2016 | 1609 | 0.530 |
Why?
|
| Neoplasm Recurrence, Local | 10 | 2019 | 9404 | 0.530 |
Why?
|
| Syntenins | 1 | 2016 | 8 | 0.530 |
Why?
|
| Transcription Factors | 9 | 2017 | 12150 | 0.520 |
Why?
|
| DNA Mutational Analysis | 16 | 2016 | 4114 | 0.520 |
Why?
|
| Kaplan-Meier Estimate | 12 | 2017 | 6512 | 0.510 |
Why?
|
| Sputum | 4 | 2013 | 514 | 0.500 |
Why?
|
| Polymorphism, Genetic | 8 | 2016 | 4249 | 0.500 |
Why?
|
| Disease-Free Survival | 17 | 2018 | 6850 | 0.500 |
Why?
|
| NF-kappa B | 3 | 2021 | 2493 | 0.500 |
Why?
|
| Gene Dosage | 3 | 2016 | 1211 | 0.500 |
Why?
|
| Epithelial-Mesenchymal Transition | 5 | 2018 | 755 | 0.500 |
Why?
|
| Bronchoscopy | 3 | 2013 | 913 | 0.500 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 15 | 2016 | 4570 | 0.490 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2021 | 949 | 0.490 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 6 | 2013 | 3246 | 0.490 |
Why?
|
| Intensive Care Units | 9 | 2010 | 3799 | 0.480 |
Why?
|
| Empyema, Pleural | 2 | 2005 | 62 | 0.480 |
Why?
|
| Heparin Cofactor II | 1 | 2014 | 3 | 0.480 |
Why?
|
| Receptor, erbB-3 | 1 | 2016 | 141 | 0.480 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2015 | 117 | 0.480 |
Why?
|
| MicroRNAs | 6 | 2014 | 3792 | 0.470 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 281 | 0.470 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2016 | 2426 | 0.470 |
Why?
|
| Survival Rate | 18 | 2016 | 12825 | 0.470 |
Why?
|
| Receptors, Steroid | 1 | 2015 | 157 | 0.470 |
Why?
|
| Radiotherapy | 2 | 2020 | 1497 | 0.470 |
Why?
|
| Epistasis, Genetic | 1 | 2016 | 353 | 0.460 |
Why?
|
| Influenza Vaccines | 2 | 2012 | 780 | 0.460 |
Why?
|
| Interleukin-15 | 1 | 2015 | 186 | 0.460 |
Why?
|
| Mycobacterium tuberculosis | 7 | 2013 | 1911 | 0.460 |
Why?
|
| Gene Expression | 5 | 2016 | 7585 | 0.450 |
Why?
|
| ras Proteins | 7 | 2015 | 1055 | 0.450 |
Why?
|
| Codon | 1 | 2016 | 599 | 0.450 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2016 | 627 | 0.440 |
Why?
|
| Drug Resistance, Neoplasm | 11 | 2018 | 5329 | 0.440 |
Why?
|
| Critical Illness | 4 | 2010 | 2750 | 0.440 |
Why?
|
| Signal Transduction | 12 | 2021 | 23619 | 0.440 |
Why?
|
| Treatment Outcome | 44 | 2018 | 65273 | 0.430 |
Why?
|
| Carcinoma | 3 | 2015 | 2324 | 0.430 |
Why?
|
| Cell Adhesion Molecules | 2 | 2012 | 1612 | 0.430 |
Why?
|
| Antibiotics, Antitubercular | 2 | 2011 | 100 | 0.420 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2014 | 385 | 0.420 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2014 | 182 | 0.420 |
Why?
|
| Minocycline | 1 | 2014 | 170 | 0.420 |
Why?
|
| Immunohistochemistry | 14 | 2021 | 11061 | 0.420 |
Why?
|
| Lymphopenia | 1 | 2015 | 299 | 0.410 |
Why?
|
| HSP40 Heat-Shock Proteins | 3 | 2010 | 85 | 0.400 |
Why?
|
| Paracrine Communication | 1 | 2014 | 277 | 0.400 |
Why?
|
| Thymidylate Synthase | 2 | 2016 | 74 | 0.400 |
Why?
|
| Carcinoma, Large Cell | 3 | 2010 | 114 | 0.400 |
Why?
|
| Mycobacterium chelonae | 1 | 2011 | 12 | 0.390 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 7 | 2016 | 1762 | 0.380 |
Why?
|
| Sp1 Transcription Factor | 2 | 2010 | 143 | 0.370 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2011 | 310 | 0.370 |
Why?
|
| Specimen Handling | 2 | 2013 | 706 | 0.370 |
Why?
|
| Polymorphism, Single Nucleotide | 19 | 2017 | 16044 | 0.360 |
Why?
|
| Proportional Hazards Models | 14 | 2016 | 12534 | 0.360 |
Why?
|
| Apoptosis | 13 | 2021 | 9513 | 0.360 |
Why?
|
| Smoking | 21 | 2020 | 9077 | 0.360 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2011 | 133 | 0.360 |
Why?
|
| Curcumin | 1 | 2011 | 97 | 0.350 |
Why?
|
| Hemothorax | 1 | 2010 | 58 | 0.350 |
Why?
|
| Fibroblasts | 4 | 2021 | 4166 | 0.350 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2012 | 180 | 0.350 |
Why?
|
| Rifampin | 2 | 2011 | 350 | 0.350 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 5 | 2007 | 592 | 0.340 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2014 | 2948 | 0.340 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 5 | 2016 | 1621 | 0.340 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2012 | 414 | 0.340 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2014 | 594 | 0.340 |
Why?
|
| Thorax | 1 | 2013 | 555 | 0.330 |
Why?
|
| Tuberculosis, Gastrointestinal | 1 | 2009 | 20 | 0.330 |
Why?
|
| Anti-Bacterial Agents | 9 | 2014 | 7475 | 0.330 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 9 | 2016 | 11872 | 0.320 |
Why?
|
| APACHE | 6 | 2010 | 268 | 0.320 |
Why?
|
| Genetic Predisposition to Disease | 17 | 2019 | 18075 | 0.320 |
Why?
|
| Creatinine | 1 | 2015 | 1917 | 0.320 |
Why?
|
| Picibanil | 1 | 2008 | 10 | 0.320 |
Why?
|
| Oncogene Proteins | 1 | 2013 | 715 | 0.320 |
Why?
|
| Cadherins | 5 | 2013 | 902 | 0.320 |
Why?
|
| Biopsy, Needle | 2 | 2012 | 1615 | 0.310 |
Why?
|
| Fluoroquinolones | 2 | 2009 | 307 | 0.310 |
Why?
|
| Pregnancy Proteins | 1 | 2009 | 222 | 0.310 |
Why?
|
| Matrix Metalloproteinases | 2 | 2020 | 391 | 0.310 |
Why?
|
| Pleural Effusion | 2 | 2009 | 344 | 0.310 |
Why?
|
| Respiratory System | 2 | 2009 | 562 | 0.310 |
Why?
|
| Membrane Proteins | 7 | 2017 | 7868 | 0.310 |
Why?
|
| Drainage | 1 | 2014 | 1182 | 0.300 |
Why?
|
| Cyclooxygenase 2 | 2 | 2008 | 596 | 0.300 |
Why?
|
| Interleukin-8 | 3 | 2015 | 702 | 0.300 |
Why?
|
| Multivariate Analysis | 12 | 2015 | 12064 | 0.300 |
Why?
|
| Blotting, Western | 7 | 2021 | 5022 | 0.300 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 693 | 0.300 |
Why?
|
| Papilloma | 1 | 2009 | 143 | 0.300 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2008 | 130 | 0.290 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2013 | 2801 | 0.290 |
Why?
|
| Retrospective Studies | 36 | 2017 | 81635 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2010 | 361 | 0.290 |
Why?
|
| Salvage Therapy | 3 | 2017 | 1274 | 0.290 |
Why?
|
| Radiology, Interventional | 1 | 2012 | 483 | 0.280 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2019 | 1071 | 0.280 |
Why?
|
| Nanotubes, Carbon | 1 | 2008 | 71 | 0.280 |
Why?
|
| Sepsis | 3 | 2015 | 2604 | 0.280 |
Why?
|
| Pneumonia, Bacterial | 2 | 2010 | 319 | 0.280 |
Why?
|
| Meningitis | 1 | 2009 | 219 | 0.280 |
Why?
|
| Gene Expression Profiling | 7 | 2016 | 9525 | 0.280 |
Why?
|
| Biopsy | 2 | 2017 | 6779 | 0.280 |
Why?
|
| Cytokines | 5 | 2013 | 7438 | 0.280 |
Why?
|
| Ipratropium | 1 | 2006 | 19 | 0.270 |
Why?
|
| Neoplasm Transplantation | 5 | 2021 | 2012 | 0.270 |
Why?
|
| Scopolamine Derivatives | 1 | 2006 | 23 | 0.270 |
Why?
|
| Cell Proliferation | 14 | 2021 | 10445 | 0.270 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 2815 | 0.270 |
Why?
|
| Mice, Inbred NOD | 6 | 2018 | 1838 | 0.270 |
Why?
|
| Abdomen | 1 | 2013 | 1137 | 0.270 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2009 | 423 | 0.270 |
Why?
|
| Animals | 38 | 2021 | 168930 | 0.270 |
Why?
|
| Mitochondria | 2 | 2021 | 3677 | 0.270 |
Why?
|
| Adjuvants, Immunologic | 1 | 2011 | 996 | 0.260 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2009 | 174 | 0.260 |
Why?
|
| Empyema | 1 | 2006 | 41 | 0.260 |
Why?
|
| Mice | 28 | 2021 | 81889 | 0.260 |
Why?
|
| Vimentin | 2 | 2021 | 257 | 0.260 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2007 | 238 | 0.260 |
Why?
|
| Cell Survival | 6 | 2021 | 5748 | 0.260 |
Why?
|
| Sequence Deletion | 5 | 2016 | 1494 | 0.260 |
Why?
|
| Adrenal Insufficiency | 1 | 2008 | 194 | 0.260 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2021 | 10745 | 0.260 |
Why?
|
| Receptor, erbB-2 | 2 | 2016 | 2597 | 0.260 |
Why?
|
| Legionnaires' Disease | 1 | 2006 | 50 | 0.260 |
Why?
|
| Mouth Neoplasms | 2 | 2021 | 595 | 0.260 |
Why?
|
| Movement | 1 | 2013 | 1468 | 0.260 |
Why?
|
| Telomerase | 2 | 2014 | 750 | 0.250 |
Why?
|
| Respiration | 2 | 2013 | 1654 | 0.250 |
Why?
|
| Cholinergic Antagonists | 1 | 2006 | 165 | 0.250 |
Why?
|
| Enzyme Activation | 5 | 2016 | 3587 | 0.250 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2021 | 3607 | 0.250 |
Why?
|
| Hepatitis B | 1 | 2011 | 709 | 0.250 |
Why?
|
| Antigens, CD | 1 | 2016 | 4032 | 0.250 |
Why?
|
| Walking | 1 | 2013 | 1201 | 0.250 |
Why?
|
| Radiation Tolerance | 1 | 2008 | 476 | 0.250 |
Why?
|
| Culture Media | 1 | 2007 | 893 | 0.250 |
Why?
|
| Endosonography | 1 | 2009 | 626 | 0.240 |
Why?
|
| Polymerase Chain Reaction | 8 | 2016 | 6066 | 0.240 |
Why?
|
| Inflammasomes | 2 | 2020 | 541 | 0.240 |
Why?
|
| Mycobacterium Infections | 1 | 2005 | 122 | 0.240 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 2062 | 0.240 |
Why?
|
| Neovascularization, Pathologic | 5 | 2020 | 2631 | 0.240 |
Why?
|
| Base Sequence | 10 | 2013 | 12415 | 0.240 |
Why?
|
| Salmonella | 1 | 2005 | 125 | 0.240 |
Why?
|
| Laryngeal Neoplasms | 1 | 2009 | 514 | 0.240 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2008 | 279 | 0.240 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2007 | 335 | 0.240 |
Why?
|
| China | 7 | 2020 | 2383 | 0.230 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2020 | 2881 | 0.230 |
Why?
|
| Respiratory Insufficiency | 2 | 2004 | 1241 | 0.230 |
Why?
|
| Pneumoconiosis | 1 | 2004 | 32 | 0.230 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2006 | 326 | 0.230 |
Why?
|
| Coal Mining | 1 | 2004 | 12 | 0.230 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 319 | 0.230 |
Why?
|
| Hospitals, University | 5 | 2010 | 572 | 0.230 |
Why?
|
| Reactive Oxygen Species | 3 | 2021 | 2142 | 0.230 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3666 | 0.230 |
Why?
|
| Pulmonary Emphysema | 1 | 2009 | 683 | 0.230 |
Why?
|
| Osteoblasts | 2 | 2020 | 1144 | 0.230 |
Why?
|
| Genotype | 12 | 2017 | 13036 | 0.230 |
Why?
|
| Carcinoma, Small Cell | 2 | 2005 | 419 | 0.230 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2016 | 220 | 0.230 |
Why?
|
| Pyrazoles | 1 | 2014 | 2030 | 0.220 |
Why?
|
| Exons | 5 | 2016 | 2392 | 0.220 |
Why?
|
| Exanthema | 1 | 2008 | 502 | 0.220 |
Why?
|
| Immunoassay | 1 | 2007 | 742 | 0.220 |
Why?
|
| Cohort Studies | 16 | 2020 | 41710 | 0.220 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2017 | 3796 | 0.220 |
Why?
|
| Transfection | 8 | 2019 | 5754 | 0.220 |
Why?
|
| Nuclear Proteins | 3 | 2016 | 5795 | 0.210 |
Why?
|
| Lambert-Eaton Myasthenic Syndrome | 1 | 2002 | 8 | 0.210 |
Why?
|
| Genome-Wide Association Study | 16 | 2020 | 12806 | 0.210 |
Why?
|
| DNA-Binding Proteins | 4 | 2013 | 9611 | 0.210 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2019 | 616 | 0.210 |
Why?
|
| Rats, Wistar | 3 | 2021 | 1889 | 0.210 |
Why?
|
| Acinetobacter Infections | 1 | 2003 | 74 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 2014 | 386 | 0.210 |
Why?
|
| Bronchodilator Agents | 1 | 2006 | 513 | 0.210 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2009 | 3511 | 0.210 |
Why?
|
| Case-Control Studies | 16 | 2020 | 22248 | 0.210 |
Why?
|
| Stomach Neoplasms | 1 | 2013 | 1474 | 0.210 |
Why?
|
| Sickness Impact Profile | 1 | 2004 | 299 | 0.200 |
Why?
|
| Pyridines | 1 | 2014 | 2888 | 0.200 |
Why?
|
| Pneumonia, Aspiration | 1 | 2003 | 145 | 0.200 |
Why?
|
| Methylprednisolone | 1 | 2004 | 387 | 0.200 |
Why?
|
| Molecular Sequence Data | 9 | 2012 | 17608 | 0.200 |
Why?
|
| Rhabdomyolysis | 1 | 2003 | 150 | 0.200 |
Why?
|
| Chemokines | 1 | 2006 | 962 | 0.200 |
Why?
|
| Macrophages, Alveolar | 1 | 2004 | 413 | 0.200 |
Why?
|
| Shock, Septic | 1 | 2009 | 772 | 0.200 |
Why?
|
| Acinetobacter baumannii | 1 | 2003 | 125 | 0.200 |
Why?
|
| Renin-Angiotensin System | 1 | 2007 | 737 | 0.200 |
Why?
|
| Mosaicism | 2 | 2016 | 480 | 0.200 |
Why?
|
| Gene Frequency | 5 | 2016 | 3624 | 0.200 |
Why?
|
| RNA Interference | 5 | 2017 | 2827 | 0.190 |
Why?
|
| Nephrotic Syndrome | 1 | 2006 | 381 | 0.190 |
Why?
|
| Radiation Pneumonitis | 1 | 2002 | 99 | 0.190 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 5 | 2018 | 505 | 0.190 |
Why?
|
| High-Frequency Jet Ventilation | 1 | 2002 | 26 | 0.190 |
Why?
|
| Lymphatic Metastasis | 4 | 2015 | 2901 | 0.190 |
Why?
|
| Rotation | 1 | 2003 | 514 | 0.190 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2008 | 1065 | 0.190 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2016 | 904 | 0.190 |
Why?
|
| Time Factors | 14 | 2015 | 40149 | 0.190 |
Why?
|
| Sincalide | 1 | 2021 | 15 | 0.190 |
Why?
|
| Viral Load | 1 | 2011 | 3385 | 0.190 |
Why?
|
| Follow-Up Studies | 12 | 2017 | 39309 | 0.190 |
Why?
|
| Prospective Studies | 16 | 2015 | 54871 | 0.190 |
Why?
|
| Predictive Value of Tests | 8 | 2017 | 15416 | 0.190 |
Why?
|
| Esterases | 1 | 2021 | 89 | 0.190 |
Why?
|
| Mucins | 1 | 2005 | 569 | 0.190 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 792 | 0.190 |
Why?
|
| Parkinson Disease | 1 | 2015 | 2884 | 0.180 |
Why?
|
| Logistic Models | 11 | 2016 | 13278 | 0.180 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2021 | 129 | 0.180 |
Why?
|
| Pleural Effusion, Malignant | 2 | 2012 | 108 | 0.180 |
Why?
|
| Cell Count | 2 | 2021 | 1826 | 0.180 |
Why?
|
| Tumor Microenvironment | 4 | 2021 | 3944 | 0.180 |
Why?
|
| RNA, Messenger | 6 | 2008 | 12791 | 0.180 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2013 | 474 | 0.180 |
Why?
|
| Mandibular Diseases | 1 | 2021 | 117 | 0.180 |
Why?
|
| Length of Stay | 4 | 2008 | 6490 | 0.180 |
Why?
|
| Hepatitis C | 1 | 2011 | 1595 | 0.180 |
Why?
|
| Protein Binding | 5 | 2016 | 9320 | 0.180 |
Why?
|
| Genetic Loci | 3 | 2016 | 2630 | 0.180 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2002 | 133 | 0.180 |
Why?
|
| Chest Tubes | 3 | 2010 | 153 | 0.180 |
Why?
|
| Cross Infection | 3 | 2006 | 1427 | 0.180 |
Why?
|
| Tracheostomy | 1 | 2004 | 430 | 0.180 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2021 | 93 | 0.170 |
Why?
|
| RNA, Small Interfering | 5 | 2014 | 3425 | 0.170 |
Why?
|
| Cells, Cultured | 6 | 2021 | 18984 | 0.170 |
Why?
|
| Pulmonary Alveoli | 1 | 2003 | 665 | 0.170 |
Why?
|
| Hydrocortisone | 1 | 2008 | 1838 | 0.170 |
Why?
|
| Laminin | 2 | 2013 | 404 | 0.170 |
Why?
|
| Physical Therapy Modalities | 1 | 2003 | 533 | 0.170 |
Why?
|
| Allyl Compounds | 1 | 2019 | 22 | 0.170 |
Why?
|
| Synovitis | 1 | 2021 | 217 | 0.170 |
Why?
|
| Risk Factors | 18 | 2020 | 74881 | 0.170 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 671 | 0.160 |
Why?
|
| Epigenesis, Genetic | 2 | 2014 | 3824 | 0.160 |
Why?
|
| Peptides, Cyclic | 1 | 2021 | 390 | 0.160 |
Why?
|
| Age Factors | 6 | 2014 | 18397 | 0.160 |
Why?
|
| Disease Progression | 7 | 2020 | 13640 | 0.160 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2008 | 1750 | 0.160 |
Why?
|
| Bronchi | 2 | 2013 | 847 | 0.160 |
Why?
|
| Drug Repositioning | 1 | 2021 | 246 | 0.160 |
Why?
|
| Asia | 3 | 2020 | 629 | 0.160 |
Why?
|
| Glucocorticoids | 2 | 2010 | 2158 | 0.160 |
Why?
|
| Up-Regulation | 6 | 2016 | 4142 | 0.160 |
Why?
|
| Odds Ratio | 9 | 2016 | 9661 | 0.160 |
Why?
|
| Lymphokines | 1 | 2002 | 924 | 0.160 |
Why?
|
| Antibodies, Viral | 2 | 2011 | 3212 | 0.160 |
Why?
|
| Cholesterol, HDL | 1 | 2005 | 1812 | 0.160 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2020 | 257 | 0.150 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 18330 | 0.150 |
Why?
|
| Autophagy | 3 | 2021 | 1346 | 0.150 |
Why?
|
| Ticlopidine | 1 | 2003 | 730 | 0.150 |
Why?
|
| Sumoylation | 1 | 2019 | 83 | 0.150 |
Why?
|
| Transplantation, Heterologous | 5 | 2017 | 2391 | 0.150 |
Why?
|
| Heme Oxygenase-1 | 1 | 2020 | 364 | 0.150 |
Why?
|
| Spleen | 1 | 2004 | 2295 | 0.150 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 1627 | 0.150 |
Why?
|
| Liver Cirrhosis | 1 | 2008 | 1960 | 0.150 |
Why?
|
| Autonomic Nervous System | 1 | 2003 | 707 | 0.150 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2020 | 382 | 0.150 |
Why?
|
| Osteoclasts | 1 | 2021 | 713 | 0.140 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2021 | 1663 | 0.140 |
Why?
|
| Bacteria | 1 | 2008 | 2212 | 0.140 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2017 | 147 | 0.140 |
Why?
|
| Disulfides | 1 | 2019 | 462 | 0.140 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2016 | 2056 | 0.140 |
Why?
|
| Immunoglobulin G | 2 | 2007 | 4559 | 0.140 |
Why?
|
| Osteosarcoma | 2 | 2020 | 908 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2021 | 2456 | 0.140 |
Why?
|
| Vitamin D | 2 | 2020 | 3270 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 3804 | 0.140 |
Why?
|
| Reproducibility of Results | 7 | 2016 | 20144 | 0.140 |
Why?
|
| Papillomavirus Infections | 1 | 2009 | 1639 | 0.140 |
Why?
|
| Chromosome Aberrations | 2 | 2015 | 1776 | 0.140 |
Why?
|
| Bacteremia | 1 | 2003 | 987 | 0.130 |
Why?
|
| Young Adult | 14 | 2017 | 59939 | 0.130 |
Why?
|
| Cysts | 1 | 2002 | 685 | 0.130 |
Why?
|
| Cell Line | 4 | 2021 | 15563 | 0.130 |
Why?
|
| DNA Probes | 2 | 2008 | 541 | 0.130 |
Why?
|
| Antigens, Nuclear | 1 | 2017 | 182 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 11920 | 0.130 |
Why?
|
| beta Catenin | 3 | 2021 | 1048 | 0.130 |
Why?
|
| Protein Isoforms | 2 | 2012 | 1716 | 0.130 |
Why?
|
| Interleukin-10 | 2 | 2015 | 1182 | 0.130 |
Why?
|
| Pharmacogenetics | 2 | 2011 | 682 | 0.130 |
Why?
|
| Genes, RAG-1 | 1 | 2015 | 68 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2016 | 287 | 0.120 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 8045 | 0.120 |
Why?
|
| Interleukin-6 | 3 | 2015 | 3227 | 0.120 |
Why?
|
| Air Pollution, Indoor | 2 | 2020 | 931 | 0.120 |
Why?
|
| Serotyping | 2 | 2006 | 331 | 0.120 |
Why?
|
| Microarray Analysis | 4 | 2014 | 751 | 0.120 |
Why?
|
| Neoplasms | 7 | 2015 | 22350 | 0.120 |
Why?
|
| Recurrence | 4 | 2014 | 8507 | 0.120 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2015 | 67 | 0.120 |
Why?
|
| Communicable Diseases, Emerging | 3 | 2006 | 149 | 0.120 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2015 | 87 | 0.120 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2014 | 10 | 0.120 |
Why?
|
| Periodontitis | 1 | 2020 | 576 | 0.120 |
Why?
|
| Mirabilis | 1 | 2014 | 1 | 0.120 |
Why?
|
| Syndecan-4 | 1 | 2014 | 45 | 0.120 |
Why?
|
| Interleukin-7 | 1 | 2015 | 146 | 0.120 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2016 | 258 | 0.120 |
Why?
|
| Disease Outbreaks | 1 | 2004 | 1761 | 0.120 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2015 | 243 | 0.120 |
Why?
|
| Metabolic Clearance Rate | 1 | 2015 | 361 | 0.120 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2016 | 125 | 0.120 |
Why?
|
| Rotenone | 1 | 2014 | 50 | 0.120 |
Why?
|
| Receptors, Somatomedin | 1 | 2014 | 57 | 0.110 |
Why?
|
| Immunoblotting | 2 | 2016 | 1647 | 0.110 |
Why?
|
| 3' Untranslated Regions | 2 | 2014 | 515 | 0.110 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2015 | 170 | 0.110 |
Why?
|
| Blotting, Northern | 2 | 2006 | 1550 | 0.110 |
Why?
|
| Chromosomes, Human, X | 1 | 2016 | 319 | 0.110 |
Why?
|
| Radiography, Thoracic | 2 | 2012 | 1320 | 0.110 |
Why?
|
| Psychometrics | 1 | 2004 | 3060 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2009 | 633 | 0.110 |
Why?
|
| Rats | 4 | 2021 | 23717 | 0.110 |
Why?
|
| Tumor Escape | 1 | 2017 | 371 | 0.110 |
Why?
|
| X Chromosome Inactivation | 1 | 2016 | 229 | 0.110 |
Why?
|
| Quality of Life | 5 | 2018 | 13476 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 2 | 2010 | 9244 | 0.110 |
Why?
|
| Drug Administration Schedule | 3 | 2012 | 4853 | 0.110 |
Why?
|
| HMGB1 Protein | 1 | 2015 | 140 | 0.110 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2014 | 318 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2020 | 2060 | 0.110 |
Why?
|
| Cell Transdifferentiation | 1 | 2014 | 186 | 0.110 |
Why?
|
| Germ-Line Mutation | 3 | 2019 | 1885 | 0.110 |
Why?
|
| Caregivers | 2 | 2018 | 2303 | 0.110 |
Why?
|
| Thoracoscopy | 1 | 2014 | 186 | 0.110 |
Why?
|
| Regression Analysis | 3 | 2008 | 6329 | 0.110 |
Why?
|
| Residual Volume | 1 | 2013 | 40 | 0.110 |
Why?
|
| Enterovirus | 1 | 2014 | 69 | 0.110 |
Why?
|
| Sex Factors | 4 | 2015 | 10619 | 0.110 |
Why?
|
| Enterovirus Infections | 1 | 2014 | 74 | 0.110 |
Why?
|
| Gene Fusion | 1 | 2016 | 356 | 0.110 |
Why?
|
| Cartilage, Articular | 1 | 2020 | 1104 | 0.110 |
Why?
|
| Comorbidity | 3 | 2014 | 10580 | 0.110 |
Why?
|
| Models, Biological | 4 | 2013 | 9461 | 0.100 |
Why?
|
| Trifluoperazine | 1 | 2012 | 40 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2015 | 20708 | 0.100 |
Why?
|
| Sequence Alignment | 2 | 2008 | 2177 | 0.100 |
Why?
|
| Dimerization | 2 | 2011 | 882 | 0.100 |
Why?
|
| Directly Observed Therapy | 1 | 2013 | 139 | 0.100 |
Why?
|
| Macrophages | 1 | 2008 | 5783 | 0.100 |
Why?
|
| Treatment Failure | 2 | 2010 | 2659 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 2 | 2013 | 2693 | 0.100 |
Why?
|
| Genome, Human | 3 | 2020 | 4443 | 0.100 |
Why?
|
| Epidermal Growth Factor | 1 | 2015 | 697 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 6 | 2018 | 6104 | 0.100 |
Why?
|
| Plethysmography | 1 | 2013 | 172 | 0.100 |
Why?
|
| Collagen Type IV | 1 | 2013 | 125 | 0.100 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 2012 | 35 | 0.100 |
Why?
|
| Thimerosal | 1 | 2012 | 15 | 0.100 |
Why?
|
| Osteoarthritis | 1 | 2020 | 1072 | 0.100 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2014 | 271 | 0.100 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2012 | 87 | 0.100 |
Why?
|
| Fucosyltransferases | 1 | 2012 | 118 | 0.100 |
Why?
|
| Adolescent | 12 | 2014 | 88904 | 0.100 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2012 | 34 | 0.100 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3432 | 0.100 |
Why?
|
| Immediate-Early Proteins | 2 | 2006 | 444 | 0.100 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2005 | 2160 | 0.100 |
Why?
|
| Incidence | 5 | 2015 | 21525 | 0.100 |
Why?
|
| Homeodomain Proteins | 2 | 2014 | 2430 | 0.100 |
Why?
|
| Narcotics | 1 | 2014 | 332 | 0.100 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 525 | 0.100 |
Why?
|
| Phosphothreonine | 1 | 2012 | 62 | 0.100 |
Why?
|
| Hospital Mortality | 5 | 2010 | 5343 | 0.100 |
Why?
|
| Brain Neoplasms | 2 | 2017 | 9101 | 0.100 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2013 | 766 | 0.100 |
Why?
|
| Tocopherols | 1 | 2011 | 43 | 0.100 |
Why?
|
| Tumor Burden | 2 | 2017 | 1900 | 0.100 |
Why?
|
| Protein Transport | 2 | 2015 | 1942 | 0.100 |
Why?
|
| Double-Blind Method | 3 | 2012 | 12430 | 0.100 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 13411 | 0.100 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2012 | 146 | 0.100 |
Why?
|
| Antigens, Bacterial | 2 | 2007 | 1148 | 0.100 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2011 | 35 | 0.100 |
Why?
|
| Necrosis | 1 | 2016 | 1616 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2015 | 2448 | 0.100 |
Why?
|
| Molecular Epidemiology | 1 | 2014 | 473 | 0.100 |
Why?
|
| Haplotypes | 2 | 2015 | 2727 | 0.090 |
Why?
|
| Heart Rate | 1 | 2003 | 4207 | 0.090 |
Why?
|
| Cricetulus | 1 | 2013 | 810 | 0.090 |
Why?
|
| Endocytosis | 1 | 2015 | 951 | 0.090 |
Why?
|
| Actinobacillus Infections | 1 | 2010 | 17 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 21162 | 0.090 |
Why?
|
| Genetic Markers | 2 | 2015 | 2603 | 0.090 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2012 | 273 | 0.090 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1105 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2003 | 2763 | 0.090 |
Why?
|
| Sequence Analysis, Protein | 1 | 2012 | 261 | 0.090 |
Why?
|
| Histocytochemistry | 1 | 2012 | 697 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2014 | 3721 | 0.090 |
Why?
|
| Radiography | 4 | 2009 | 6968 | 0.090 |
Why?
|
| Bone Neoplasms | 2 | 2020 | 2561 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2014 | 496 | 0.090 |
Why?
|
| Hemoptysis | 1 | 2012 | 152 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2012 | 8307 | 0.090 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2011 | 163 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2014 | 376 | 0.090 |
Why?
|
| Alleles | 4 | 2016 | 6895 | 0.090 |
Why?
|
| CHO Cells | 1 | 2013 | 1376 | 0.090 |
Why?
|
| Transaminases | 1 | 2011 | 198 | 0.090 |
Why?
|
| Azacitidine | 1 | 2012 | 335 | 0.090 |
Why?
|
| Cell Adhesion | 3 | 2013 | 3093 | 0.090 |
Why?
|
| Latent Tuberculosis | 1 | 2013 | 223 | 0.080 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2014 | 1442 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 6b | 1 | 2009 | 2 | 0.080 |
Why?
|
| Genes, ras | 2 | 2013 | 656 | 0.080 |
Why?
|
| Mutation, Missense | 2 | 2019 | 2590 | 0.080 |
Why?
|
| Transcription Factor AP-2 | 1 | 2010 | 78 | 0.080 |
Why?
|
| Amino Acid Substitution | 2 | 2011 | 1742 | 0.080 |
Why?
|
| Interferon Type I | 1 | 2014 | 568 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 1969 | 0.080 |
Why?
|
| Ubiquitination | 2 | 2011 | 1007 | 0.080 |
Why?
|
| Pancreatic Elastase | 1 | 2009 | 124 | 0.080 |
Why?
|
| Radiotherapy Dosage | 2 | 2010 | 2911 | 0.080 |
Why?
|
| Binding Sites | 3 | 2013 | 6012 | 0.080 |
Why?
|
| Hepatic Insufficiency | 1 | 2009 | 14 | 0.080 |
Why?
|
| Cricetinae | 1 | 2013 | 2416 | 0.080 |
Why?
|
| Neutropenia | 1 | 2015 | 894 | 0.080 |
Why?
|
| RNA, Neoplasm | 1 | 2012 | 747 | 0.080 |
Why?
|
| Epirubicin | 2 | 2008 | 82 | 0.080 |
Why?
|
| Expressed Sequence Tags | 1 | 2010 | 251 | 0.080 |
Why?
|
| Contact Tracing | 1 | 2011 | 274 | 0.080 |
Why?
|
| Tuberculosis, Pleural | 1 | 2009 | 14 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2009 | 7871 | 0.080 |
Why?
|
| Inteins | 1 | 2008 | 9 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 1150 | 0.080 |
Why?
|
| Dinucleotide Repeats | 1 | 2008 | 28 | 0.080 |
Why?
|
| Hypoventilation | 1 | 2009 | 44 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2020 | 3139 | 0.080 |
Why?
|
| Gadolinium DTPA | 1 | 2012 | 823 | 0.080 |
Why?
|
| Osteonecrosis | 1 | 2010 | 230 | 0.080 |
Why?
|
| Prevalence | 3 | 2016 | 15835 | 0.080 |
Why?
|
| DNA Glycosylases | 1 | 2009 | 125 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 3 | 2012 | 4780 | 0.080 |
Why?
|
| Telomere | 1 | 2014 | 943 | 0.080 |
Why?
|
| Liver | 1 | 2004 | 7571 | 0.080 |
Why?
|
| Mice, Nude | 2 | 2013 | 3616 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 7609 | 0.080 |
Why?
|
| Stem Cells | 1 | 2021 | 3537 | 0.080 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2009 | 755 | 0.080 |
Why?
|
| Meningeal Carcinomatosis | 1 | 2008 | 65 | 0.070 |
Why?
|
| Cost of Illness | 1 | 2018 | 1949 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 1491 | 0.070 |
Why?
|
| Radiosurgery | 1 | 2017 | 1329 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 1117 | 0.070 |
Why?
|
| Exercise Test | 2 | 2013 | 2188 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2006 | 1657 | 0.070 |
Why?
|
| Substrate Specificity | 1 | 2012 | 1750 | 0.070 |
Why?
|
| Chromatography | 1 | 2007 | 189 | 0.070 |
Why?
|
| Rest | 1 | 2013 | 940 | 0.070 |
Why?
|
| Mycobacterium | 1 | 2009 | 252 | 0.070 |
Why?
|
| Platinum Compounds | 1 | 2008 | 94 | 0.070 |
Why?
|
| Forced Expiratory Volume | 1 | 2013 | 1828 | 0.070 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2010 | 461 | 0.070 |
Why?
|
| Cisplatin | 3 | 2012 | 1655 | 0.070 |
Why?
|
| ROC Curve | 2 | 2013 | 3620 | 0.070 |
Why?
|
| Models, Genetic | 2 | 2008 | 3450 | 0.070 |
Why?
|
| Mice, Inbred ICR | 1 | 2008 | 361 | 0.070 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2009 | 142 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 2251 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2011 | 1756 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2015 | 14471 | 0.070 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2016 | 2028 | 0.070 |
Why?
|
| Chest Pain | 1 | 2014 | 1101 | 0.070 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2008 | 170 | 0.070 |
Why?
|
| Uterine Neoplasms | 1 | 2016 | 1424 | 0.070 |
Why?
|
| Pneumonectomy | 1 | 2014 | 1147 | 0.070 |
Why?
|
| Duodenal Ulcer | 1 | 2007 | 117 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2021 | 11651 | 0.070 |
Why?
|
| Anxiety | 2 | 2013 | 4670 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 547 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 3702 | 0.070 |
Why?
|
| Metered Dose Inhalers | 1 | 2006 | 28 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2010 | 8540 | 0.070 |
Why?
|
| Exercise Tolerance | 1 | 2012 | 847 | 0.070 |
Why?
|
| Multiple Organ Failure | 1 | 2009 | 389 | 0.070 |
Why?
|
| Response Elements | 1 | 2008 | 308 | 0.070 |
Why?
|
| DNA Gyrase | 1 | 2007 | 86 | 0.070 |
Why?
|
| Serine Endopeptidases | 1 | 2012 | 1027 | 0.070 |
Why?
|
| Endocarditis, Bacterial | 1 | 2010 | 436 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4276 | 0.070 |
Why?
|
| Proteoglycans | 1 | 2009 | 806 | 0.070 |
Why?
|
| Cefotaxime | 1 | 2006 | 36 | 0.070 |
Why?
|
| Sulbactam | 1 | 2006 | 32 | 0.070 |
Why?
|
| Captopril | 1 | 2007 | 261 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2009 | 559 | 0.070 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 15908 | 0.070 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2006 | 95 | 0.070 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2012 | 1205 | 0.070 |
Why?
|
| Risk | 4 | 2015 | 9602 | 0.060 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2007 | 200 | 0.060 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 1392 | 0.060 |
Why?
|
| Terminal Care | 1 | 2018 | 1769 | 0.060 |
Why?
|
| Ampicillin | 1 | 2006 | 138 | 0.060 |
Why?
|
| Legionella pneumophila | 1 | 2006 | 50 | 0.060 |
Why?
|
| Drug Administration Routes | 1 | 2005 | 152 | 0.060 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 1874 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2012 | 1504 | 0.060 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 2005 | 195 | 0.060 |
Why?
|
| Kallikreins | 1 | 2006 | 219 | 0.060 |
Why?
|
| Vinblastine | 1 | 2007 | 482 | 0.060 |
Why?
|
| Chemokine CXCL10 | 1 | 2006 | 311 | 0.060 |
Why?
|
| Computational Biology | 3 | 2015 | 3564 | 0.060 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 399 | 0.060 |
Why?
|
| YY1 Transcription Factor | 1 | 2005 | 60 | 0.060 |
Why?
|
| DNA Methylation | 3 | 2016 | 4427 | 0.060 |
Why?
|
| Anemia | 1 | 2015 | 1514 | 0.060 |
Why?
|
| Lung Abscess | 1 | 2005 | 39 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2012 | 938 | 0.060 |
Why?
|
| Bacteria, Anaerobic | 1 | 2005 | 71 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2006 | 420 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 1677 | 0.060 |
Why?
|
| Patient Care | 1 | 2010 | 629 | 0.060 |
Why?
|
| Diagnostic Errors | 1 | 2012 | 1276 | 0.060 |
Why?
|
| Decision Trees | 1 | 2007 | 508 | 0.060 |
Why?
|
| Medical Records | 1 | 2010 | 1408 | 0.060 |
Why?
|
| Gelatinases | 1 | 2004 | 93 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22352 | 0.060 |
Why?
|
| CA-19-9 Antigen | 1 | 2005 | 109 | 0.060 |
Why?
|
| Mucin 5AC | 1 | 2005 | 96 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 2902 | 0.060 |
Why?
|
| Ventilators, Mechanical | 1 | 2007 | 292 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2012 | 2201 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2015 | 2903 | 0.060 |
Why?
|
| Remission Induction | 1 | 2010 | 2413 | 0.060 |
Why?
|
| Epithelial Cells | 2 | 2013 | 3691 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2010 | 4168 | 0.060 |
Why?
|
| Family | 2 | 2013 | 3209 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2006 | 454 | 0.060 |
Why?
|
| Gangliosides | 1 | 2005 | 132 | 0.060 |
Why?
|
| Disinfection | 1 | 2006 | 207 | 0.060 |
Why?
|
| Hospitalization | 1 | 2004 | 10823 | 0.060 |
Why?
|
| Estrogens | 1 | 2011 | 1528 | 0.060 |
Why?
|
| Microsatellite Repeats | 1 | 2006 | 784 | 0.060 |
Why?
|
| Loss of Heterozygosity | 1 | 2006 | 663 | 0.060 |
Why?
|
| Apolipoprotein A-I | 1 | 2005 | 305 | 0.060 |
Why?
|
| Phenotype | 3 | 2018 | 16724 | 0.060 |
Why?
|
| Antigens, Surface | 2 | 2005 | 1617 | 0.060 |
Why?
|
| 5' Untranslated Regions | 1 | 2005 | 255 | 0.060 |
Why?
|
| Translations | 1 | 2004 | 84 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2007 | 562 | 0.050 |
Why?
|
| Beds | 1 | 2003 | 48 | 0.050 |
Why?
|
| Collagen | 2 | 2009 | 2635 | 0.050 |
Why?
|
| Helicobacter pylori | 1 | 2007 | 380 | 0.050 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2004 | 187 | 0.050 |
Why?
|
| Microcirculation | 2 | 2006 | 1282 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2009 | 2085 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 4410 | 0.050 |
Why?
|
| Sensitivity and Specificity | 4 | 2016 | 14652 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2016 | 370 | 0.050 |
Why?
|
| Pneumococcal Vaccines | 1 | 2007 | 414 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2008 | 2669 | 0.050 |
Why?
|
| DNA Repair | 1 | 2012 | 2050 | 0.050 |
Why?
|
| Klebsiella pneumoniae | 1 | 2005 | 253 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 1604 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2009 | 1756 | 0.050 |
Why?
|
| Immunotherapy | 2 | 2016 | 4747 | 0.050 |
Why?
|
| Diaphragm | 1 | 2004 | 357 | 0.050 |
Why?
|
| Antioxidants | 2 | 2021 | 1671 | 0.050 |
Why?
|
| Intestines | 1 | 2011 | 1904 | 0.050 |
Why?
|
| Viruses | 1 | 2006 | 371 | 0.050 |
Why?
|
| Depression | 2 | 2013 | 8228 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 4652 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 2228 | 0.050 |
Why?
|
| Proteomics | 1 | 2015 | 3914 | 0.050 |
Why?
|
| Acid Phosphatase | 1 | 2021 | 141 | 0.050 |
Why?
|
| Catenins | 1 | 2021 | 44 | 0.050 |
Why?
|
| Paclitaxel | 2 | 2007 | 1727 | 0.050 |
Why?
|
| Bronchial Fistula | 1 | 2002 | 83 | 0.050 |
Why?
|
| Streptococcus pneumoniae | 1 | 2007 | 764 | 0.050 |
Why?
|
| Annexin A1 | 1 | 2020 | 22 | 0.050 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2020 | 116 | 0.050 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 1751 | 0.050 |
Why?
|
| Immunoprecipitation | 3 | 2010 | 874 | 0.050 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 1477 | 0.050 |
Why?
|
| Nausea | 1 | 2004 | 681 | 0.040 |
Why?
|
| Pleural Diseases | 1 | 2002 | 138 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2004 | 1337 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2005 | 1527 | 0.040 |
Why?
|
| Deoxycytidine | 3 | 2012 | 886 | 0.040 |
Why?
|
| Air Pollutants | 1 | 2015 | 2931 | 0.040 |
Why?
|
| Respiratory Tract Infections | 1 | 2008 | 1008 | 0.040 |
Why?
|
| Coal | 1 | 2020 | 124 | 0.040 |
Why?
|
| Frizzled Receptors | 1 | 2020 | 86 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2021 | 610 | 0.040 |
Why?
|
| Vomiting | 1 | 2004 | 652 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 2005 | 1227 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2007 | 1972 | 0.040 |
Why?
|
| Cytosine Deaminase | 1 | 2020 | 63 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 748 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 3439 | 0.040 |
Why?
|
| Glutathione Peroxidase | 1 | 2021 | 258 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2003 | 582 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 3041 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2005 | 865 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2020 | 164 | 0.040 |
Why?
|
| Wound Healing | 1 | 2011 | 2800 | 0.040 |
Why?
|
| Fistula | 1 | 2002 | 213 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2005 | 2274 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 1514 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4619 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2006 | 1895 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2005 | 1334 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 2846 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2015 | 8066 | 0.040 |
Why?
|
| Garlic | 1 | 2019 | 28 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 2021 | 262 | 0.040 |
Why?
|
| Ethambutol | 2 | 2009 | 59 | 0.040 |
Why?
|
| Age Distribution | 1 | 2005 | 2869 | 0.040 |
Why?
|
| DNA Primers | 3 | 2011 | 2826 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2006 | 2201 | 0.040 |
Why?
|
| Kidney | 1 | 2014 | 7074 | 0.040 |
Why?
|
| Antipsychotic Agents | 1 | 2012 | 3078 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 718 | 0.040 |
Why?
|
| Peptide Nucleic Acids | 1 | 2018 | 28 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2007 | 4018 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2004 | 746 | 0.040 |
Why?
|
| Bone Regeneration | 1 | 2021 | 437 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 4349 | 0.040 |
Why?
|
| Glutathione | 1 | 2021 | 589 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 5789 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2021 | 595 | 0.040 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2019 | 281 | 0.040 |
Why?
|
| Carcinogens | 1 | 2020 | 452 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2006 | 6214 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2006 | 2926 | 0.040 |
Why?
|
| Gingiva | 1 | 2020 | 422 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2006 | 1390 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2011 | 3591 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2018 | 271 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2015 | 24295 | 0.040 |
Why?
|
| Aging | 1 | 2016 | 8731 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 10384 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 949 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2019 | 730 | 0.030 |
Why?
|
| Acrylamides | 1 | 2018 | 260 | 0.030 |
Why?
|
| Proteome | 1 | 2007 | 1894 | 0.030 |
Why?
|
| Asia, Southeastern | 1 | 2016 | 115 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 36567 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2013 | 5992 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2019 | 661 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 1331 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2020 | 1057 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2006 | 2057 | 0.030 |
Why?
|
| Neutrophils | 1 | 2009 | 3782 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 987 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 8106 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2006 | 5890 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2010 | 1168 | 0.030 |
Why?
|
| Chondrocytes | 1 | 2020 | 799 | 0.030 |
Why?
|
| Adaptation, Psychological | 2 | 2018 | 2662 | 0.030 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2006 | 91 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 615 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2004 | 1805 | 0.030 |
Why?
|
| Registries | 1 | 2011 | 8351 | 0.030 |
Why?
|
| Pneumonia | 1 | 2006 | 2159 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 4353 | 0.030 |
Why?
|
| Medicine, Tibetan Traditional | 1 | 2014 | 2 | 0.030 |
Why?
|
| Heredity | 1 | 2015 | 149 | 0.030 |
Why?
|
| Hong Kong | 1 | 2014 | 169 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 2 | 2008 | 895 | 0.030 |
Why?
|
| Pedigree | 2 | 2015 | 4539 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2014 | 14762 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2014 | 107 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2016 | 432 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2005 | 2978 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2021 | 2931 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 3833 | 0.030 |
Why?
|
| Cell Fusion | 1 | 2014 | 294 | 0.030 |
Why?
|
| Medical Waste | 1 | 2013 | 16 | 0.030 |
Why?
|
| Singapore | 1 | 2014 | 299 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 6962 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2016 | 534 | 0.030 |
Why?
|
| Plant Roots | 1 | 2014 | 121 | 0.030 |
Why?
|
| Morbidity | 1 | 2019 | 1754 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 545 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2021 | 2413 | 0.030 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2014 | 61 | 0.030 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2014 | 75 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2019 | 1044 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2019 | 1250 | 0.030 |
Why?
|
| Penetrance | 1 | 2015 | 388 | 0.030 |
Why?
|
| Microvilli | 1 | 2013 | 234 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 1086 | 0.030 |
Why?
|
| Acute Disease | 1 | 2004 | 7241 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2014 | 378 | 0.030 |
Why?
|
| Aniline Compounds | 1 | 2018 | 1079 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 4215 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 328 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1405 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2014 | 591 | 0.030 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2012 | 57 | 0.030 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2012 | 85 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2011 | 6976 | 0.030 |
Why?
|
| Uterus | 1 | 2016 | 661 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2012 | 275 | 0.020 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2012 | 200 | 0.020 |
Why?
|
| Family Health | 1 | 2016 | 1254 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2013 | 369 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2012 | 361 | 0.020 |
Why?
|
| Sialic Acids | 1 | 2011 | 122 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2012 | 418 | 0.020 |
Why?
|
| Bacteriological Techniques | 1 | 2012 | 277 | 0.020 |
Why?
|
| Fucose | 1 | 2011 | 115 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2012 | 191 | 0.020 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2011 | 100 | 0.020 |
Why?
|
| Progestins | 1 | 2012 | 300 | 0.020 |
Why?
|
| Quadriceps Muscle | 1 | 2012 | 157 | 0.020 |
Why?
|
| Aromatase | 1 | 2011 | 147 | 0.020 |
Why?
|
| Pathology, Molecular | 1 | 2013 | 329 | 0.020 |
Why?
|
| DNA Repair Enzymes | 1 | 2012 | 342 | 0.020 |
Why?
|
| Japan | 1 | 2014 | 1417 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2011 | 423 | 0.020 |
Why?
|
| Biosynthetic Pathways | 1 | 2011 | 138 | 0.020 |
Why?
|
| Oxygen | 1 | 2002 | 4251 | 0.020 |
Why?
|
| RNA | 2 | 2013 | 2715 | 0.020 |
Why?
|
| 5-Methylcytosine | 1 | 2010 | 146 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2014 | 643 | 0.020 |
Why?
|
| Streptomycin | 1 | 2009 | 69 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2011 | 6507 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2012 | 369 | 0.020 |
Why?
|
| Aza Compounds | 1 | 2009 | 34 | 0.020 |
Why?
|
| Ofloxacin | 1 | 2009 | 66 | 0.020 |
Why?
|
| Pyrazinamide | 1 | 2009 | 60 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 805 | 0.020 |
Why?
|
| Anilides | 1 | 2012 | 413 | 0.020 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2011 | 250 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 1676 | 0.020 |
Why?
|
| Glycosylation | 1 | 2011 | 1099 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 3073 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 2394 | 0.020 |
Why?
|
| Piperazines | 1 | 2018 | 2547 | 0.020 |
Why?
|
| Isoniazid | 1 | 2009 | 279 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2012 | 1996 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2006 | 5182 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2012 | 639 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2009 | 416 | 0.020 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2008 | 121 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2009 | 614 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2012 | 1326 | 0.020 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2012 | 614 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 3236 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 283 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2011 | 581 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2010 | 1154 | 0.020 |
Why?
|
| Stress, Psychological | 2 | 2013 | 4527 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2009 | 608 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2017 | 2645 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2003 | 8926 | 0.020 |
Why?
|
| Chromosome Disorders | 1 | 2009 | 498 | 0.020 |
Why?
|
| Introns | 1 | 2008 | 966 | 0.020 |
Why?
|
| Oximetry | 1 | 2009 | 461 | 0.020 |
Why?
|
| Heating | 1 | 2006 | 103 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1434 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2008 | 638 | 0.020 |
Why?
|
| Endonucleases | 1 | 2008 | 371 | 0.020 |
Why?
|
| Delayed Diagnosis | 1 | 2009 | 454 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 1697 | 0.020 |
Why?
|
| Point Mutation | 1 | 2010 | 1591 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2009 | 1606 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2013 | 2136 | 0.010 |
Why?
|
| Protein Multimerization | 1 | 2010 | 960 | 0.010 |
Why?
|
| Fatigue | 1 | 2012 | 1555 | 0.010 |
Why?
|
| Species Specificity | 1 | 2009 | 2413 | 0.010 |
Why?
|
| Causality | 1 | 2010 | 1252 | 0.010 |
Why?
|
| Computer-Aided Design | 1 | 2006 | 290 | 0.010 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1642 | 0.010 |
Why?
|
| Positive-Pressure Respiration | 1 | 2009 | 712 | 0.010 |
Why?
|
| Dyspnea | 1 | 2012 | 1352 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2009 | 1691 | 0.010 |
Why?
|
| Child | 3 | 2009 | 80668 | 0.010 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2008 | 878 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2009 | 42577 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2921 | 0.010 |
Why?
|
| Quinolines | 1 | 2009 | 769 | 0.010 |
Why?
|
| Postmenopause | 1 | 2012 | 2517 | 0.010 |
Why?
|
| Klebsiella Infections | 1 | 2005 | 146 | 0.010 |
Why?
|
| Acetylation | 1 | 2006 | 1054 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2010 | 1110 | 0.010 |
Why?
|
| Helicobacter Infections | 1 | 2007 | 390 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 2184 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2007 | 996 | 0.010 |
Why?
|
| Fibronectins | 1 | 2006 | 722 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 3757 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2005 | 472 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 2746 | 0.010 |
Why?
|
| Syndrome | 1 | 2009 | 3271 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2013 | 5306 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2006 | 1525 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 2470 | 0.010 |
Why?
|
| Polysomnography | 1 | 2009 | 1868 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 2510 | 0.010 |
Why?
|
| Data Collection | 1 | 2011 | 3321 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2004 | 462 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2011 | 5386 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2010 | 2870 | 0.010 |
Why?
|
| Probability | 1 | 2006 | 2476 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2013 | 26310 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12985 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 3853 | 0.010 |
Why?
|
| Virus Diseases | 1 | 2006 | 720 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2012 | 3043 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 2198 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 7841 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 6307 | 0.010 |
Why?
|
| Contrast Media | 1 | 2012 | 5329 | 0.010 |
Why?
|
| Plasmids | 1 | 2004 | 2268 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 4282 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2011 | 3957 | 0.010 |
Why?
|
| Pain | 1 | 2013 | 5098 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2012 | 3989 | 0.010 |
Why?
|
| Echocardiography | 1 | 2010 | 5037 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 6222 | 0.010 |
Why?
|
| Antibodies | 1 | 2005 | 2421 | 0.010 |
Why?
|
| Weight Loss | 1 | 2009 | 2712 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2012 | 6612 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2010 | 4306 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2008 | 6259 | 0.010 |
Why?
|
| Vaccination | 1 | 2007 | 3434 | 0.010 |
Why?
|
| Infant | 1 | 2015 | 36461 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2009 | 26389 | 0.000 |
Why?
|